Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Myeloma Patient-Derived MCL1 Point Mutations Can Influence MCL1-Inhibitor Function

Brandon Chen, Wong Pamela, B.S., Daniel Auclair, PhD, Jonathan J Keats, PhD, Paul Secrist, PhD, Justin Cidado, PhD, Adriana E. Tron, PhD, Christine M Dunham, PhD, Sagar Lonial, MD, Joseph Opferman, PhD, Shannon M Matulis, PhD, Lawrence H. Boise, PhD

Blood (2018) 132 (Supplement 1): 951.

https://doi.org/10.1182/blood-2018-99-113444

Published: 2018

Journal Articles

Targeting Mcl-1 for Multiple Myeloma (MM) Therapy: Drug-Induced Generation of Mcl-1 Fragment Mcl-1 128–350 Triggers MM Cell Death V ia c- Jun Upregulation

Fengjuan Fan, PhD, Giovanni Tonon, MD PhD, Martin Sattler, PhD, Alexander Schimming, Hartmut Goldschmidt, MD, PhD, Joseph Opferman, Ph.D, Kenneth C. Anderson, MD, Dirk Jaeger, MD, Klaus Podar, MD, PhD

Blood (2012) 120 (21): 3959.

https://doi.org/10.1182/blood.V120.21.3959.3959

Published: 2012

Journal Articles

Conserved Transcriptional Deregulation Underlies GFI1 and ELANE Mutant Neutropenia

H. Andre Olsson, Ph.D, Andrew Plassard, Phillip Dexheimer, James D. Phelan, B.S., Ari Melnick, MD, Jun Xia, Daniel C. Link, MD, Joseph Opferman, Ph.D, Bruce J Aronow, PhD, H. Leighton Grimes, PhD

Blood (2011) 118 (21): 13.

https://doi.org/10.1182/blood.V118.21.13.13

Published: 2011

Journal Articles

Myc Induces Acute Myeloid Leukemia by Conferring Self-Renewal Activity to Committed Myeloid Progenitor Cells That Resist Apoptosis Via Endogenous Mcl-1.

Hui Luo, PhD, Jennifer A. Cain, PhD, AnnaLynn Molitoris, MS, Joseph Opferman, PhD, Michael H. Tomasson, MD

Blood (2007) 110 (11): 2634.

https://doi.org/10.1182/blood.V110.11.2634.2634

Published: 2007

Journal Articles

A Gene Expression Connectivity Map Identifies Rapamycin as a Glucocorticoid Resistance Reversal Agent in Lymphoblastic Leukemia.

Scott A. Armstrong, MD, PhD, Guo Wei, PhD, Justin Lamb, PhD, Joseph Opferman, PhD, David Twomey, Ronald Stam, PhD, Monique den Boer, PhD, Stephen E. Sallan, MD, Rob Pieters, MD, Todd R. Golub, MD

Blood (2005) 106 (11): 108.

https://doi.org/10.1182/blood.V106.11.108.108

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Myeloma Patient-Derived MCL1 Point Mutations Can Influence MCL1-Inhibitor Function

Targeting Mcl-1 for Multiple Myeloma (MM) Therapy: Drug-Induced Generation of Mcl-1 Fragment Mcl-1 128–350 Triggers MM Cell Death V ia c- Jun Upregulation

Conserved Transcriptional Deregulation Underlies GFI1 and ELANE Mutant Neutropenia

Myc Induces Acute Myeloid Leukemia by Conferring Self-Renewal Activity to Committed Myeloid Progenitor Cells That Resist Apoptosis Via Endogenous Mcl-1.

A Gene Expression Connectivity Map Identifies Rapamycin as a Glucocorticoid Resistance Reversal Agent in Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Update search

Myeloma Patient-Derived MCL1 Point Mutations Can Influence MCL1-Inhibitor Function

Targeting Mcl-1 for Multiple Myeloma (MM) Therapy: Drug-Induced Generation of Mcl-1 Fragment Mcl-1 128–350 Triggers MM Cell Death V ia c- Jun Upregulation

Conserved Transcriptional Deregulation Underlies GFI1 and ELANE Mutant Neutropenia

Myc Induces Acute Myeloid Leukemia by Conferring Self-Renewal Activity to Committed Myeloid Progenitor Cells That Resist Apoptosis Via Endogenous Mcl-1.

A Gene Expression Connectivity Map Identifies Rapamycin as a Glucocorticoid Resistance Reversal Agent in Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only